TWD 28.55
(-9.94%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 109.9 Million TWD | 249.51% |
2022 | 31.44 Million TWD | 239.26% |
2021 | 9.26 Million TWD | 565.4% |
2020 | 1.39 Million TWD | -4.65% |
2019 | 1.46 Million TWD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 35.55 Million TWD | -10.15% |
2024 Q2 | 37.26 Million TWD | 4.82% |
2023 Q4 | 39.57 Million TWD | 87.92% |
2023 FY | 109.9 Million TWD | 249.51% |
2023 Q3 | 21.05 Million TWD | -45.26% |
2023 Q2 | 38.46 Million TWD | 255.66% |
2023 Q1 | 10.81 Million TWD | -1.65% |
2022 FY | 31.44 Million TWD | 239.26% |
2022 Q4 | 10.99 Million TWD | 0.0% |
2021 FY | 9.26 Million TWD | 565.4% |
2020 FY | 1.39 Million TWD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 728 Thousand TWD | -14997.253% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 1.11 Billion TWD | 90.14% |
Level Biotechnology Inc. | 660.61 Million TWD | 83.363% |
Sagittarius Life Science Corp | 440.46 Million TWD | 75.047% |
NeoCore Technology Co., Ltd. | 64.72 Million TWD | -69.797% |
TaiMed Biologics Inc. | 491.77 Million TWD | 77.651% |
GlycoNex Incorporation | 2.54 Million TWD | -4223.682% |
VBI | 55.85 Million TWD | -96.781% |
GeneReach Biotechnology Corp. | 225.46 Million TWD | 51.252% |
Taiwan Advance Bio-Pharmaceutical Inc. | 315.98 Million TWD | 65.217% |
SynCore Biotechnology Co.,Ltd | 20.19 Million TWD | -444.207% |
Genomics BioSci & Tech. Co.,Ltd. | 396.14 Million TWD | 72.255% |
Visgeneer Inc. | 147.99 Million TWD | 25.735% |
Mycenax Biotech Inc. | 652.62 Million TWD | 83.159% |
Sunmax Biotechnology Co., Ltd. | 1.68 Billion TWD | 93.493% |
G&E Herbal Biotechnology Co., Ltd. | 181.44 Million TWD | 39.426% |
Neith Corporation | 39.9 Million TWD | -175.438% |
Medigen Vaccine Biologics Corporation | 389.62 Million TWD | 71.791% |
TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | -383.282% |
Enimmune corporation | 43.49 Million TWD | -152.697% |
TaiRx, Inc. | 5.08 Million TWD | -2062.692% |
CHO Pharma, Inc. | - TWD | -Infinity% |
EirGenix Inc. | 1.02 Billion TWD | 89.253% |
BioLASCO Taiwan Co., Ltd. | 264.72 Million TWD | 58.482% |
Sunny Pharmtech Inc. | 428.82 Million TWD | 74.37% |
Lin BioScience, Inc. | - TWD | -Infinity% |
Feng Chi Biotech Corp. | 180.57 Million TWD | 39.135% |
Bio Preventive Medicine Corp. | 1.2 Million TWD | -8998.344% |
Lukas Biomedical Inc. | 231.83 Million TWD | 52.592% |
RBC Bioscience Corporation | 172.46 Million TWD | 36.273% |
BiOptic Inc. | 228.26 Million TWD | 51.852% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -122020.0% |
Shine-On BioMedical Co.,Ltd. | 9.52 Million TWD | -1054.011% |
Great Novel Therapeutics Biotech & Medicals | 4.85 Million TWD | -2166.144% |
Syngen Biotech Co.,Ltd. | 1.83 Billion TWD | 94.018% |
Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
NaviFUS Corp. | 22.48 Million TWD | -388.893% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 141.17 Million TWD | 22.148% |
Sinew Pharma Inc. | - TWD | -Infinity% |
Andros Pharmaceuticals Co.,Ltd | 805 Thousand TWD | -13553.168% |
Greenyn Biotechnology Co., Ltd | 800.51 Million TWD | 86.27% |
Lumosa Therapeutics Co., Ltd. | 56.91 Million TWD | -93.106% |
AP Biosciences Inc | 32.25 Million TWD | -240.768% |
Medigen Biotechnology Corp. | 1.15 Billion TWD | 90.507% |
3D Global Biotech Inc. | 20.63 Million TWD | -432.681% |
Pharmosa Biopharm Inc. | 314.5 Million TWD | 65.053% |
Intech Biopharm Corporation | 25.84 Million TWD | -325.225% |
Oneness Biotech Co., Ltd. | 86.78 Million TWD | -26.647% |
Eusol Biotech Co.,Ltd. | - TWD | -Infinity% |
TWi Biotechnology, Inc. | - TWD | -Infinity% |
Ever Supreme Bio Technology Co., Ltd | 758.39 Million TWD | 85.508% |
TCI GENE Inc. | 333.85 Million TWD | 67.079% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -610500.0% |
Senhwa Biosciences, Inc. | 1 Million TWD | -10890.8% |
Taiwan Bio Therapeutics Co., Ltd | 85.47 Million TWD | -28.592% |
NatureWise Biotech & Medicals Corporation | 160.14 Million TWD | 31.368% |
PharmaEngine, Inc. | 767.66 Million TWD | 85.683% |
Savior Lifetec Corporation | 1.05 Billion TWD | 89.535% |
TaiGen Biopharmaceuticals Holdings Limited | 123.13 Million TWD | 10.741% |
OBI Pharma, Inc. | 41.54 Million TWD | -164.526% |
Meribank Biotech Co., Ltd | 234.34 Million TWD | 53.099% |
Acepodia, Inc. | 16.59 Million TWD | -562.376% |
Caliway Biopharmaceuticals Co., Ltd. | 38.93 Million TWD | -182.308% |